NFE2L2 and glioblastoma: In the p53-wild-type GBM, the classical p62-mediated NRF2 activation pathway plays a major role in regulating iron cell apoptosis, thus leading to increased SLC7A11 expression and acting as an anti-iron cell apoptosis mechanism (Ma et al., 2020).